NCT06030752View on ClinicalTrials.gov

WMT for Autism Spectrum Disorder (ASD)

PHASE1RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 20, 2023

Primary Completion Date

April 4, 2027

Study Completion Date

May 1, 2027

Conditions
Autism Spectrum Disorder
Interventions
DRUG

Washed Microbiota Transplantation

The prepared microbiota suspension was infused into the participates' lower gut.

Trial Locations (2)

Unknown

RECRUITING

Department of Microbiota Medicine & Medical Centre for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing

RECRUITING

SIR RUN RUN hospital of Nanjing Medical University, Nanjing

Sponsors
All Listed Sponsors
collaborator

Nanjing Medical University

OTHER

lead

The Second Hospital of Nanjing Medical University

OTHER

NCT06030752 - WMT for Autism Spectrum Disorder (ASD) | Biotech Hunter | Biotech Hunter